Dolby Laboratories, Inc. (NYSE:DLB) Stock Holdings Increased by Quantinno Capital Management LP

Quantinno Capital Management LP lifted its position in Dolby Laboratories, Inc. (NYSE:DLB) by 12.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 8,592 shares of the electronics maker’s stock after acquiring an additional 932 shares during the period. Quantinno Capital Management LP’s holdings in Dolby Laboratories were worth $658,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Ninety One UK Ltd boosted its holdings in Dolby Laboratories by 2.6% in the second quarter. Ninety One UK Ltd now owns 2,344,963 shares of the electronics maker’s stock worth $185,791,000 after purchasing an additional 60,114 shares during the period. Disciplined Growth Investors Inc. MN lifted its position in shares of Dolby Laboratories by 0.8% in the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 1,402,623 shares of the electronics maker’s stock worth $111,130,000 after buying an additional 10,852 shares during the last quarter. Boston Trust Walden Corp boosted its holdings in shares of Dolby Laboratories by 185.3% in the 3rd quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker’s stock valued at $82,276,000 after buying an additional 698,283 shares during the period. Mackenzie Financial Corp grew its position in shares of Dolby Laboratories by 3.5% during the 2nd quarter. Mackenzie Financial Corp now owns 1,010,230 shares of the electronics maker’s stock valued at $80,041,000 after buying an additional 33,848 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Dolby Laboratories by 27.0% during the second quarter. Dimensional Fund Advisors LP now owns 792,828 shares of the electronics maker’s stock worth $62,817,000 after acquiring an additional 168,744 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Trading Down 1.3 %

NYSE DLB opened at $79.18 on Friday. The company has a 50-day moving average price of $75.86 and a two-hundred day moving average price of $75.77. Dolby Laboratories, Inc. has a 52 week low of $66.35 and a 52 week high of $89.28. The stock has a market cap of $7.56 billion, a price-to-earnings ratio of 29.22 and a beta of 0.98.

Dolby Laboratories Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.67%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. The ex-dividend date was Tuesday, December 3rd. Dolby Laboratories’s dividend payout ratio is 48.71%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on DLB. Barrington Research reaffirmed an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Wednesday, November 20th. Rosenblatt Securities boosted their price objective on Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday, November 20th. Finally, StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, December 4th.

Insider Activity at Dolby Laboratories

In other news, CAO Ryan Nicholson sold 10,500 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $80.18, for a total value of $841,890.00. Following the completion of the transaction, the chief accounting officer now owns 24,364 shares of the company’s stock, valued at approximately $1,953,505.52. This represents a 30.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the sale, the chief executive officer now owns 83,721 shares in the company, valued at approximately $6,205,400.52. This represents a 25.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 152,091 shares of company stock worth $12,027,697 in the last three months. 39.54% of the stock is owned by company insiders.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.